Optimal therapeutic strategy for treating patients with hypertension and atherosclerosis: focus on olmesartan medoxomil

Cardiovascular (CV) disease is a major factor in mortality rates around the world and contributes to more than one-third of deaths in the US. The underlying cause of CV disease is atherosclerosis, a chronic inflammatory process that is clinically manifested as coronary artery disease, carotid artery...

Полное описание

Библиографические подробности

Главный автор:	R. P. Mason
Формат:	Artigo
Язык:	Russo
Опубликовано:	«SILICEA-POLIGRAF» LLC 2012-06-01
Серии:	Кардиоваскулярная терапия и профилактика
Предметы:	angiotensin ii receptor blocker antihypertensive atherosclerotic process cardiovascular outcomes coronary artery disease olmesartan medoxomil raas suppression
Online-ссылка:	https://cardiovascular.elpub.ru/jour/article/view/1839
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!